{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T13:30:24Z","timestamp":1696167024941},"reference-count":45,"publisher":"Informa Healthcare","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2016,4,2]]},"DOI":"10.1517\/14740338.2016.1157163","type":"journal-article","created":{"date-parts":[[2016,2,22]],"date-time":"2016-02-22T06:52:49Z","timestamp":1456123969000},"page":"549-557","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Safety and efficacy of once daily ledipasvir\/sofosbuvir fixed-dose combination in patients with chronic hepatitis C"],"prefix":"10.1517","volume":"15","author":[{"given":"N.","family":"Gamal","sequence":"first","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Andreone","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2016,3,7]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27950"},{"key":"CIT0002","unstructured":"World Health Organization. Hepatitis C factsheet No 164; April 2014. [October 22] Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs164\/en\/"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2010.03432.x"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02537.x"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260720"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3248"},{"key":"CIT0007","unstructured":"Harvoni (ledipasvir-sofosbuvir) tablets: U.S. prescribing information. Foster City CGS; cited 2015 March. Available from: http:\/\/www.gilead.com\/~\/media\/Files\/pdfs\/medicines\/liver-disease\/harvoni\/harvoni_pi.pdf"},{"key":"CIT0008","volume-title":"15th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy","author":"German PYJ"},{"key":"CIT0009","volume-title":"in humans 8th International Workshop on Clinical Pharmacology of Hepatitis Therapy","author":"Kirby BMA"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.03.025"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.346"},{"key":"CIT0012","unstructured":"FDA Drug Safety Communication: FDA warns of serious slowing of the heart rate when antiarrhythmic drug amiodarone is used with hepatitis C treatments containing sofosbuvir (Harvoni) or Sovaldi in combination with another Direct Acting Antiviral drug; [cited 2015 November 28]. Available from: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm439484.htm"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62121-2"},{"issue":"736","key":"CIT0014","first-page":"e1","volume":"146","author":"Gane EJ","year":"2014","journal-title":"Gastroenterology"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402454"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402355"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1316366"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00157-7"},{"key":"CIT0019","first-page":"Abstract 92","volume-title":"AASLD","author":"Wilson E"},{"key":"CIT0020","volume-title":"AASLD","author":"Pungpapong S"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.05.010"},{"key":"CIT0022","volume-title":"Presented at: International Liver Congress","author":"Manns MFX"},{"key":"CIT0023","volume-title":"AASLD","author":"Gane EJ"},{"key":"CIT0024","volume-title":"15th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy","author":"German PYJ"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.1373"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501315"},{"issue":"1454","key":"CIT0027","first-page":"e1","volume":"149","author":"Gane EJ","year":"2015","journal-title":"Gastroenterology"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)70050-2"},{"key":"CIT0029","volume-title":"AASLD","author":"Gane EJ"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27826"},{"key":"CIT0031","first-page":"S620","volume-title":"Annual meeting of the Europen Association for the Study of the Liver (EASL)","volume":"62","author":"Samuel D"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2997"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12791"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27922"},{"key":"CIT0035","unstructured":"VIEKIRA PAK [package insert]. North Chicago, IL: AbbVie Inc; 2015."},{"key":"CIT0036","unstructured":"Simeprevir (OLYSIO \u00ae) full prescribing information. Available from: http:\/\/www.olysio.com\/shared\/product\/olysio\/prescribing-information.pdf."},{"key":"CIT0037","volume-title":"Presented at The annual meeting of the American association for the study of the Liver diseases (AASLD)","author":"Bernstein DMR"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.2174\/092986706778773059"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402869"},{"key":"CIT0040","volume-title":"AASLD","author":"Pockros PJ"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27814"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512610"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512612"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512614"},{"key":"CIT0045","author":"European Association for the Study of the Liver. Electronic address eee","year":"2015","journal-title":"J Hepatol"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14740338.2016.1157163","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T08:28:46Z","timestamp":1599380926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14740338.2016.1157163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,7]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4,2]]}},"alternative-id":["10.1517\/14740338.2016.1157163"],"URL":"https:\/\/doi.org\/10.1517\/14740338.2016.1157163","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,7]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-12-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-02-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-03-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}